Funding or sponsored research
What we have achieved to date: (i) Benchmark Ambrosia’s proprietary technology in an industry-relevant environment (TRL6) – demonstrate and quantify the technological advantage. This has been challenged and confirmed by experts. (ii) Ensure freedom to operate, file patents in the relevant geographies. (iii) Build partnerships across the value chain, from technology partners to sugar producers, distributors, and leading F&B companies. And, (iv) produce pilot batches of allulose, share with both production partners and FMCG.
What we are aiming to achieve by 2027: (i) Obtain our own regulatory credential. Leverage the GRAS self-assessment dossier to additional geographies and conclude the enzyme’s safety assessment for EFSA. (ii) Increase allulose production capacity, first with Seprosys at our pilot plant, and later with a partner to demonstrate industrial proof-of-scale. (iii) Increase allulose-epimerase (the enzyme) production capacity to support early adopters. And (iv) use the produced allulose to enter the Japanese, South Korean, and US markets. Benefit from short-term premium pricing.
About Ambrosia Bio Ltd.
Ambrosia Bio is a biotechnology company that has developed a proprietary enzyme-based platform designed to convert common sugars and feedstocks, such as sucrose, into rare, low-calorie sugars like allulose. The company’s approach involves a plug-and-play bioprocess that integrates into existing sugar refinery and starch processing infrastructure, allowing manufacturers to produce these high-value ingredients without significant operational modifications. By utilizing synthetic enzymes that demonstrate high stability and catalytic activity, the platform offers a cost-effective alternative to traditional production methods, aiming to overcome the scale and affordability barriers associated with mass-market allulose adoption.
This technology provides food and beverage manufacturers with a solution to reduce sugar content in consumer products while maintaining the taste profile, texture, and sensory experience of traditional sugar. By enabling producers to diversify their portfolios between conventional and health-focused ingredients, Ambrosia Bio supports the industry's shift toward healthier food options, particularly for diabetic patients and weight-conscious consumers. The company has engaged in strategic partnerships, including collaborations with Ginkgo Bioworks to further optimize its enzyme expression strains and production processes, as it works with international food and beverage producers to implement its sugar reduction solutions.
delivered to your inbox.